No Link Between Acetaminophen Use in Pregnancy and Autism, Major Danish Study Finds
Large Danish study finds no link between acetaminophen (Tylenol) use in pregnancy and autism, contradicting Trump-era claims.
Large Danish study finds no link between acetaminophen (Tylenol) use in pregnancy and autism, contradicting Trump-era claims.
Aldi advises against squeezing avocados to check ripeness, as it bruises the fruit. Instead, use the palm of your hand or check the stalk.
UK's biggest drugmaker upgrades US listing to direct NYSE listing, keeps London listing and Cambridge HQ.
Two men arrested in UK's largest seizure of unlicensed weight-loss drugs at Northampton country estate; 12,000 doses recovered.
Glenmark recalls over 11,100 bottles of Ziac blood pressure tablets after cross-contamination with cholesterol drug ezetimibe.
Texas AG Ken Paxton sues Pfizer for allegedly exaggerating Covid-19 vaccine effectiveness, seeking penalties over $10m.
European pharma stocks hit four-month low as Trump repeats tariff threats; Bayer, Novo Nordisk fall; firms like AstraZeneca boost US investment.
Many common medications and supplements can cause pill-induced oesophagitis, leading to pain, inflammation, and rare but serious complications.
About one in eight US adults are taking appetite-curbing drugs like Ozempic, potentially shifting Thanksgiving traditions and eating habits.
A 13-year-old girl died within 24 hours of a cancer diagnosis after being misdiagnosed with a chest infection and given antibiotics.
Five major publishers and author Scott Turow sue Meta, alleging unauthorised use of millions of works to train Llama AI models.
Novo Nordisk's diabetes drug sales slow, facing competition and tariffs; cost cuts and possible layoffs announced as market value drops.
Sam Neill announces he is cancer-free after CAR T-cell therapy clinical trial in Australia, advocates for broader access.
James Norton completed his first London Marathon in 4 hours 29 minutes, raising £132,000 for Breakthrough TD1.
Jeremy Clarkson reveals three-stone weight loss using Mounjaro, causing his shoe size to shrink and requiring a new wardrobe.
US bankruptcy judge approves Purdue Pharma's opioid settlement, requiring Sackler family to pay up to $7bn.
Nearly 400 UK medicines, including cancer and stroke drugs, are at risk of shortages due to lack of suppliers, NHS England warns.
Sweat may cause plastic-based workout clothing to release harmful chemicals like flame retardants and bisphenols, which can be absorbed through the skin.
The Ordinary's new £13.50 growth factor serum shows promising anti-ageing results after three weeks of use, says beauty editor.
Australia's TGA warns that weight-loss drugs like Ozempic may increase suicidal thoughts and Mounjaro may reduce contraception effectiveness.
Research finds subtle language changes like long-winded speech could signal Alzheimer's years before diagnosis, aiding early detection.
Beta blockers like propranolol are becoming a Hollywood trend for calming nerves, but what are the risks and benefits?
Eli Lilly CEO Dave Ricks says UK is worst in Europe for drug prices, warns of investment loss unless pricing regime changes.
Lorraine regular Claer Barret lost four stone and three dress sizes using Mounjaro, discussing the 'calculated risk' and lifestyle overhaul.
Sanofi executive Paul Naish says Britain is a 'terrible place' to sell medicines, urging government to raise spending and update drug pricing rules.
Pascal Soriot warns Europe and US risk being outpaced on innovation as happened in the car industry, as AstraZeneca aims for 2030 sales of $80bn.
GSK reports rising profits but warns of slower 2026 growth as new CEO Luke Miels navigates patent expiries and vaccine uncertainty.
Expert explains 'Ozempic mouth' side effect: hollowing and skin laxity around the mouth from rapid weight loss due to drugs like Ozempic.
Donald Trump announces plan to reduce prices of GLP-1 weight loss drugs and expand Medicare coverage, with injectables averaging $350 monthly.
UK considers raising NHS drug payments by 25% amid standoff with pharma industry and US tariff threats, affecting cost-effectiveness thresholds.